Search research articles
Contact Us
Filters
Showing results (671-680 of 710) with videos related to
Page
of 71
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2018
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads
Krista Kinneer, John Meekin, Arnaud C Tiberghien, et al.
Bioconjugate Chemistry
|
September 3, 2015
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry
Michael P VanBrunt, Kurt Shanebeck, Zachary Caldwell, et al.
International Journal of Environmental Health Research
|
January 18, 2025
Associations between anthropogenic heat emissions and serum lipids among adults in northeastern China
Jianping Cong, Hong-Zhi Zhang, Ming-Kun Sun, et al.
Journal of Medicinal Chemistry
|
March 12, 2010
Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agents
Dyeison Antonow, Maciej Kaliszczak, Gyoung-Dong Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2017
Fractionated Dosing Improves Preclinical Therapeutic Index of Pyrrolobenzodiazepine-Containing Antibody Drug Conjugates
Mary Jane Masson Hinrichs, Pauline M Ryan, Bo Zheng, et al.
Cancer Research
|
September 18, 2004
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity
John A Hartley, Victoria J Spanswick, Natalie Brooks, et al.
Leukemia
|
October 14, 2018
Preclinical assessment of an antibody-PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cells
Krista Kinneer, Matt Flynn, Suneetha B Thomas, et al.
Basic Research in Cardiology
|
November 28, 2012
Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury
Nan Wang, Elke De Vuyst, Raf Ponsaerts, et al.
Molecular Cancer Therapeutics
|
March 3, 2021
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR
Shenlan Mao, Raghothama Chaerkady, Wen Yu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 21, 2025
Cognitive outcomes of deep brain stimulation depend on age and hippocampal connectivity in Parkinson's and Alzheimer's disease
Calvin W Howard, Martin Reich, Lan Luo, et al.
Page
of 71
Search research articles
Search
Showing results (671-680 of 710) with videos related to
Sort By:
Page
of 71
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2018
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads
Krista Kinneer, John Meekin, Arnaud C Tiberghien, et al.
Bioconjugate Chemistry
|
September 3, 2015
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry
Michael P VanBrunt, Kurt Shanebeck, Zachary Caldwell, et al.
International Journal of Environmental Health Research
|
January 18, 2025
Associations between anthropogenic heat emissions and serum lipids among adults in northeastern China
Jianping Cong, Hong-Zhi Zhang, Ming-Kun Sun, et al.
Journal of Medicinal Chemistry
|
March 12, 2010
Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agents
Dyeison Antonow, Maciej Kaliszczak, Gyoung-Dong Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2017
Fractionated Dosing Improves Preclinical Therapeutic Index of Pyrrolobenzodiazepine-Containing Antibody Drug Conjugates
Mary Jane Masson Hinrichs, Pauline M Ryan, Bo Zheng, et al.
Cancer Research
|
September 18, 2004
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity
John A Hartley, Victoria J Spanswick, Natalie Brooks, et al.
Leukemia
|
October 14, 2018
Preclinical assessment of an antibody-PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cells
Krista Kinneer, Matt Flynn, Suneetha B Thomas, et al.
Basic Research in Cardiology
|
November 28, 2012
Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury
Nan Wang, Elke De Vuyst, Raf Ponsaerts, et al.
Molecular Cancer Therapeutics
|
March 3, 2021
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR
Shenlan Mao, Raghothama Chaerkady, Wen Yu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 21, 2025
Cognitive outcomes of deep brain stimulation depend on age and hippocampal connectivity in Parkinson's and Alzheimer's disease
Calvin W Howard, Martin Reich, Lan Luo, et al.
Page
of 71